Review

Next-generation photodynamic cancer therapy: purpurin-based nanocarriers as emerging photosensitizers.

Yash D. Dudhwala Riya K. Mehta Md. Ali Mujtaba Visha M. Nayak Nitin G. Haswani Vipin Saini Devesh U. Kapoor

Aug 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 63 references

Medicine

TL;DR

This review critically examines purpurin-18 and related chlorin-based nanocarriers as next-generation photosensitizer systems for PDT to advance purpurin-18-based nano-PDT toward clinical applicability.

DOI PubMed Semantic Scholar

View source

Similar papers

Sep 2026

Two-photon photodynamic induction of PANoptosis and immunogenic cell death for precision tumor eradication using a dual-organelle-targeted STING agonist.

This study addresses triple-negative breast cancer treatment by developing a photosensitizer, DBC, with a multiple-twist molecular architecture, offering broader readers an impactful paradigm for engineering multi-functional biomaterials to combat aggressive cancers.

Hao Ren, Da-Lu Xie, Wen-Zhao Shang et al. · Acta Biomaterialia · 0 citations

Open access Sep 2026

A Vanadium(II) Photosensitizer Delivered by Human Serum Albumin for Photodynamic Therapy

Photodynamic therapy (PDT) is an established clinically approved treatment; however, the development of next-generation photosensitizers remains constrained by the reliance on scarce precious-metal scaffolds and poor pharmacological properties. Earth-abundant first−row transition metals offer an attractive alternativ...

Zisis Papadopoulos, Aimée Marie Irgel, Alexandra König-Schäfer et al. · Journal of Medicinal Chemist... · 0 citations

Sep 2026

Se-sensitized NIR-II merocyanine photosensitizer for mitochondria-targeted Type I photodynamic therapy of breast cancer in mice.

Breast cancer is one of the most prevalent malignant tumors affecting women worldwide and poses a serious threat to women's health and survival. Accordingly, the development of effective technologies for breast cancer treatment has received considerable attention in biomedicine and materials chemistry. Here, push-pull...

Qi-Long Zhang, Xu Zhou, Xue Wang et al. · Journal of Colloid and Inter... · 0 citations

Aug 2026

A lipid droplet-targeted AIE photosensitizer for efficient multi-type ROS generation and breast cancer photodynamic therapy.

A novel lipid droplet-targeted aggregation-induced emission photosensitizer CTC was designed and synthesized, providing a novel candidate and new insight for safe and efficient breast cancer PDT.

Yukun Zhang, Lidong Deng, Qi-Yan Li et al. · Bioorganic chemistry (Print) · 0 citations

Review Open access Aug 2026

Photodynamic Therapy in Cancer: Mechanisms, Photosensitizer Technology, Vitamin Modulation, and Rational Combination Design

Overall, PDT combination design should be guided by whether adjunctive agents support or undermine photosensitizer accumulation, oxygen availability, ROS-mediated cytotoxicity, and immune activation, when selected according to mechanistic compatibility.

Ilaf Naser, D. Bartusik-Aebisher, Barbara Smolak et al. · Biomedicines · 1 citation

Sep 2026

Overcoming Solubility and Aggregation: Water-Soluble Porphyrins in Modern Phototherapy

Photodynamic therapy (PDT) is a minimally invasive cancer treatment that works through the combined use of photosensitizers (PS), light, and molecular oxygen to generate reactive oxygen species. Several porphyrin-based photosensitizers have been clinically developed for PDT, with Photofrin being one of the most commo...

Gayathri M. P., Jotiba P. Powar, Balaji Babu · Molecular Pharmaceutics · 0 citations